Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
Human adenoviruses from multiple species bind to coagulation factor X (FX), yet the importance of this interaction in adenovirus dissemination is unknown. Upon contact with blood, vectors based on adenovirus serotype 5 (Ad5) binds to FX via the hexon protein with nanomolar affinity, leading to selective uptake of the complex into the liver and spleen. The Ad5:FX complex putatively targets heparan sulfate proteoglycans (HSPGs). The aim of this study was to elucidate the specific requirements for Ad5:FX-mediated cellular uptake in this high-affinity pathway, specifically the HSPG receptor requirements as well as the role of penton base-mediated integrin engagement in subsequent internalisation. Removal of HS sidechains by enzymatic digestion or competition with highly-sulfated heparins/heparan sulfates significantly decreased FX-mediated Ad5 cell binding in vitro and ex vivo. Removal of N-linked and, in particular, O-linked sulfate groups significantly attenuated the inhibitory capabilities of heparin, while the chemical inhibition of endogenous HSPG sulfation dose-dependently reduced FX-mediated Ad5 cellular uptake. Unlike native heparin, modified heparins lacking O- or N-linked sulfate groups were unable to inhibit Ad5 accumulation in the liver 1h after intravascular administration of adenovirus. Similar results were observed in vitro using Ad5 vectors possessing mutations ablating CAR- and/or αv integrin binding, demonstrating that attachment of the Ad5:FX complex to the cell surface involves HSPG sulfation. Interestingly, Ad5 vectors ablated for αv integrin binding showed markedly delayed cell entry, highlighting the need for an efficient post-attachment internalisation signal for optimal Ad5 uptake and transport following surface binding mediated through FX. This study therefore integrates the established model of αv integrin-dependent adenoviral infection with the high-affinity FX-mediated pathway. This has important implications for mechanisms that define organ targeting following contact of human adenoviruses with blood.
Vyšlo v časopise:
Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001142
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001142
Souhrn
Human adenoviruses from multiple species bind to coagulation factor X (FX), yet the importance of this interaction in adenovirus dissemination is unknown. Upon contact with blood, vectors based on adenovirus serotype 5 (Ad5) binds to FX via the hexon protein with nanomolar affinity, leading to selective uptake of the complex into the liver and spleen. The Ad5:FX complex putatively targets heparan sulfate proteoglycans (HSPGs). The aim of this study was to elucidate the specific requirements for Ad5:FX-mediated cellular uptake in this high-affinity pathway, specifically the HSPG receptor requirements as well as the role of penton base-mediated integrin engagement in subsequent internalisation. Removal of HS sidechains by enzymatic digestion or competition with highly-sulfated heparins/heparan sulfates significantly decreased FX-mediated Ad5 cell binding in vitro and ex vivo. Removal of N-linked and, in particular, O-linked sulfate groups significantly attenuated the inhibitory capabilities of heparin, while the chemical inhibition of endogenous HSPG sulfation dose-dependently reduced FX-mediated Ad5 cellular uptake. Unlike native heparin, modified heparins lacking O- or N-linked sulfate groups were unable to inhibit Ad5 accumulation in the liver 1h after intravascular administration of adenovirus. Similar results were observed in vitro using Ad5 vectors possessing mutations ablating CAR- and/or αv integrin binding, demonstrating that attachment of the Ad5:FX complex to the cell surface involves HSPG sulfation. Interestingly, Ad5 vectors ablated for αv integrin binding showed markedly delayed cell entry, highlighting the need for an efficient post-attachment internalisation signal for optimal Ad5 uptake and transport following surface binding mediated through FX. This study therefore integrates the established model of αv integrin-dependent adenoviral infection with the high-affinity FX-mediated pathway. This has important implications for mechanisms that define organ targeting following contact of human adenoviruses with blood.
Zdroje
1. RussellWC
2009 Adenoviruses: update on structure and function. J Gen Virol 90 1 20
2. HongJY
LeeHJ
PiedraPA
ChoiEH
ParkKH
2001 Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis. Clin Infect Dis 32 1423 1429
3. EchavarriaM
2008 Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 21 704 715
4. KojaoghlanianT
FlomenbergP
HorwitzMS
2003 The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 13 155 171
5. Blackwell Munsgardt 2004 Adenovirus. Am J Transplant 4 Suppl 10 101 104
6. LionT
BaumgartingerR
WatzingerF
Matthes-MartinS
SudaM
2003 Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102 1114 1120
7. MunozFM
PiedraPA
DemmlerGJ
1998 Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 27 1194 1200
8. Leruez-VilleM
MinardV
LacailleF
BuzynA
AbachinE
2004 Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 38 45 52
9. TakayamaR
HatakeyamaN
SuzukiN
YamamotoM
HayashiT
2007 Quantification of adenovirus species B and C viremia by real-time PCR in adults and children undergoing stem cell transplantation. J Med Virol 79 278 284
10. BergelsonJM
CunninghamJA
DroguettG
Kurt-JonesEA
KrithivasA
1997 Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275 1320 1323
11. LawLK
DavidsonBL
2005 What does it take to bind CAR? Mol Ther 12 599 609
12. WickhamTJ
MathiasP
ChereshDA
NemerowGR
1993 Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73 309 319
13. WickhamTJ
FilardoEJ
ChereshDA
NemerowGR
1994 Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 127 257 264
14. AlemanyR
CurielDT
2001 CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther 8 1347 1353
15. MartinK
BrieA
SaulnierP
PerricaudetM
YehP
2003 Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol Ther 8 485 494
16. NicolCG
GrahamD
MillerWH
WhiteSJ
SmithTA
2004 Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats. Mol Ther 10 344 354
17. ParkerAL
WaddingtonSN
NicolCG
ShayakhmetovDM
BuckleySM
2006 Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108 2554 2561
18. Di PaoloNC
ShayakhmetovDM
2009 Adenovirus de-targeting from the liver. Curr Opin Mol Ther 11 523 531
19. CoyneCB
BergelsonJM
2005 CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 57 869 882
20. KalyuzhniyO
Di PaoloNC
SilvestryM
HofherrSE
BarryMA
2008 Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105 5483 5488
21. WaddingtonSN
McVeyJH
BhellaD
ParkerAL
BarkerK
2008 Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132 397 409
22. MadischI
WolfelR
HarsteG
PommerH
HeimA
2006 Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients. J Med Virol 78 1210 1217
23. KampmannB
CubittD
WallsT
NaikP
DepalaM
2005 Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 130 595 603
24. EskoJD
LindahlU
2001 Molecular diversity of heparan sulfate. J Clin Invest 108 169 173
25. BishopJR
SchukszM
EskoJD
2007 Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446 1030 1037
26. EndressT
LampeM
BriggsJA
KrausslichHG
BrauchleC
2008 HIV-1-cellular interactions analyzed by single virus tracing. Eur Biophys J 37 1291 1301
27. JohnsonKM
KinesRC
RobertsJN
LowyDR
SchillerJT
2009 Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83 2067 2074
28. SummerfordC
SamulskiRJ
1998 Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72 1438 1445
29. ShuklaD
LiuJ
BlaiklockP
ShworakNW
BaiX
1999 A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99 13 22
30. ShayakhmetovDM
GaggarA
NiS
LiZY
LieberA
2005 Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79 7478 7491
31. LyonM
DeakinJA
GallagherJT
1994 Liver heparan sulfate structure. A novel molecular design. J Biol Chem 269 11208 11215
32. MacArthurJM
BishopJR
StanfordKI
WangL
BensadounA
2007 Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117 153 164
33. VongchanP
WardaM
ToyodaH
ToidaT
MarksRM
2005 Structural characterization of human liver heparan sulfate. Biochim Biophys Acta 1721 1 8
34. KaliaM
ChandraV
RahmanSA
SehgalD
JameelS
2009 Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J Virol 83 12714 12724
35. TiwariV
O'DonnellCD
OhMJ
Valyi-NagyT
ShuklaD
2005 A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread. Biochem Biophys Res Commun 338 930 937
36. KimM
ZinnKR
BarnettBG
SumerelLA
KrasnykhV
2002 The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer 38 1917 1926
37. BoyleMP
EnkeRA
ReynoldsJB
MogayzelPJJr
GugginoWB
2006 Membrane-associated heparan sulfate is not required for rAAV-2 infection of human respiratory epithelia. Virol J 3 29
38. O'DonnellJ
TaylorKA
ChapmanMS
2009 Adeno-associated virus-2 and its primary cellular receptor–Cryo-EM structure of a heparin complex. Virology 385 434 443
39. ZautnerAE
KornerU
HenkeA
BadorffC
SchmidtkeM
2003 Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol 77 10071 10077
40. ShayakhmetovDM
EberlyAM
LiZY
LieberA
2005 Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J Virol 79 1053 1061
41. SmithTA
IdamakantiN
RollenceML
Marshall-NeffJ
KimJ
2003 Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum Gene Ther 14 777 787
42. HidakaC
MilanoE
LeopoldPL
BergelsonJM
HackettNR
1999 CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest 103 579 587
43. GreberU
PuntenerD
2009 DNA tumour virus entry- from plasma membrane to the nucleus. Semin Cell Dev Biol 20 631 642
44. SafaiyanF
KolsetSO
PrydzK
GottfridssonE
LindahlU
1999 Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem 274 36267 36273
45. EskoJD
WeinkeJL
TaylorWH
EkborgG
RodenL
1987 Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J Biol Chem 262 12189 12195
46. BameKJ
EskoJD
1989 Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase. J Biol Chem 264 8059 8065
47. BaiX
EskoJD
1996 An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation. J Biol Chem 271 17711 17717
48. BasuA
KandaT
BeyeneA
SaitoK
MeyerK
2007 Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. J Virol 81 3933 3941
49. XuZ
TianJ
SmithJS
ByrnesAP
2008 Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J Virol 82 11705 11713
50. SmithJS
XuZ
TianJ
StevensonSC
ByrnesAP
2008 Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver. Hum Gene Ther 19 547 554
51. ShashkovaEV
DoroninK
SenacJS
BarryMA
2008 Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus. Cancer Res 68 5896 5904
52. Di PaoloNC
van RooijenN
ShayakhmetovDM
2009 Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver. Mol Ther 17 675 684
53. ShiehMT
WuDunnD
MontgomeryRI
EskoJD
SpearPG
1992 Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol 116 1273 1281
54. BarthH
SchaferC
AdahMI
ZhangF
LinhardtRJ
2003 Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 278 41003 41012
55. AsokanA
ConwayJC
PhillipsJL
LiC
HeggeJ
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat Biotechnol 28 79 82
56. PeraboL
GoldnauD
WhiteK
EndellJ
BoucasJ
2006 Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism. J Virol 80 7265 7269
57. StanfordKI
WangL
CastagnolaJ
SongD
BishopJR
Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. J Biol Chem 285 286 294
58. SakaiT
KisielW
1990 Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. Evidence that factor Xa binds to tumor cells independent of factor Va. J Biol Chem 265 9105 9113
59. KazamaY
KomiyamaY
KisielW
1993 Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface. Blood 81 676 682
60. CraftJ
EppsK
BrancatoS
SerfisA
2003 Incorporation of blood clotting factor X into phospholipid model membranes: fluorescence microscopy imaging and subphase effects surrounding the lipid phase transition region. Journal of Colloid and Interface Science 268 181 187
61. SabharwalAK
PadmanabhanK
TulinskyA
MathurA
GorkaJ
1997 Interaction of calcium with native and decarboxylated human factor X. Effect of proteolysis in the autolysis loop on catalytic efficiency and factor Va binding. J Biol Chem 272 22037 22045
62. ScanduraJM
AhmadSS
WalshPN
1996 A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin. Biochemistry 35 8890 8902
63. PlesciaJ
AltieriDC
1996 Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 319 Pt 3 873 879
64. TuveS
WangH
JacobsJD
YumulRC
SmithDF
2008 Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog 4 e1000189
65. KritzAB
NicolCG
DishartKL
NelsonR
HolbeckS
2007 Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop. Mol Ther 15 741 749
66. AlbaR
BradshawAC
ParkerAL
BhellaD
WaddingtonSN
2009 Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114 965 971
67. RezaieAR
1998 Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa. J Biol Chem 273 16824 16827
68. RezaieAR
2000 Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J Biol Chem 275 3320 3327
69. GhoshT
ChattopadhyayK
MarschallM
KarmakarP
MandalP
2009 Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation. Glycobiology 19 2 15
70. HuskensD
VermeireK
ProfyAT
ScholsD
2009 The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1. Antiviral Res 84 38 47
71. FletcherPS
WallaceGS
MesquitaPM
ShattockRJ
2006 Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. Retrovirology 3 46
72. Von SeggernDJ
KehlerJ
EndoRI
NemerowGR
1998 Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein. J Gen Virol 79 Pt 6 1461 1468
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 10
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Retroviral RNA Dimerization and Packaging: The What, How, When, Where, and Why
- Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice
- Antimicrobial Peptides: Primeval Molecules or Future Drugs?
- Crystal Structure of DotD: Insights into the Relationship between Type IVB and Type II/III Secretion Systems